BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Lanatosides

The Extra Pharmacopoeia, 30th ed, p670)

115+ PubMed studies analyzed · Evidence Score: 35

Research Domains

Lanatosides has been studied across 9 research domains including ❤️ Cardiovascular, 🫁 Respiratory, 🔥 Metabolic, 🧠 Focus & Attention, 😴 Sleep. The primary research focus is ❤️ Cardiovascular with 41% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Lanatosides, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Strophanthidin
23 shared targets
Digitoxigenin
20 shared targets
Tubercidin
17 shared targets
Digoxigenin
18 shared targets
Anisomycin
18 shared targets
Digoxin
23 shared targets
Carbazilquinone
9 shared targets
clofilium
11 shared targets
cycloheximide
16 shared targets
tyrphostin
14 shared targets
Loading evidence profile...

This evidence profile for Lanatosides is generated deterministically from 115 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.